Research from UAB suggests that nearly half of children with the most common type of leukemia or their parents say they took more medications than they actually did.
Christine Curcio, Ph.D., led an international team of researchers that developed a culture system for age-related macular degeneration, the third most prevalent cause of vision loss worldwide.
Daniel C. Bullard, Ph.D., has been named assistant dean for Undergraduate Biomedical Programs in the School of Medicine, a new position created to oversee established joint undergraduate degree programs and develop new biomedical undergraduate majors.
UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
The award recognizes a significant paper by Cui in Cell Death and Differentiation.
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
Abnormal antibody production that allows inflammation leading to AIDS is detected by analysis of antibodies in gut fluid of HIV-1-infected people.
UAB’s innovative Patient Care Connect Program utilizes lay navigation and provides a cost-effective new model for cancer care delivery.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
Five faculty members in the School of Medicine have been named the 2016 class of James A. Pittman Jr., M.D., Scholars, a program organized to recognize the contributions of junior faculty and support the retention of highly competitive scientists and physician-scientists.
Page 15 of 103